{"name":"Invectys","slug":"invectys","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNb2dXclFKVW5sd0pnUTluQ05KakdLSnFGaXk3dXhrLXJYeEFpV2E0LWdTQ3lBVzNVLTFCRlVhV2pIMHhneDBlRHNiZXhmc3ozXzdFRG0yYjFXQVBwUEswYl9DS0ZmbUVjNDRWS1VHQnVSR3ZLMU1FT0NYTnhFUDdvSk1nNGxNMzhBdU1wRnRB?oc=5","date":"2024-02-07","type":"trial","source":"Oncology Pipeline","summary":"Gilead deals more checkpoint disappointment | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Gilead deals more checkpoint disappointment | ApexOnco - Clinical Trials news and analysis","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQSUJvVnpIYkUybERDR2xjbVV1Q2RmWDk2cUFkVlhPa0Zwakw5b1dtSDZwYzhuRzVkcTNINFJhQVdVc2hvUWVYUms2LTQ1QVN2V3FuaFFtLU56b2FhN3ljWDROR2dlOTdEMGZDZDhBVWtSaGlYVXNidWl1UFlscmFaUDhrcDk4RUJZVi1SYmpKemhnS2EyWmp6cFZyeThVa0pJckNxOUREWEhMblE?oc=5","date":"2023-08-01","type":"regulatory","source":"Pharmaceutical Technology","summary":"FDA fast-tracks Invectys’ CAR-T therapy for renal cell carcinoma - Pharmaceutical Technology","headline":"FDA fast-tracks Invectys’ CAR-T therapy for renal cell carcinoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQbWFGTm5KQVd3UEo5cTk5NFpmRTFOeVVac3hTLURoS2NKVk8zR1liMmN6MTFaWVdza05rS2Fmb0RuY1lOd3FGT2F3YjJaNEF6NVFfTGFpSjFOTnUzdkFvMjJTSDNMRmZqUWZZY2I5Z1NoWGdJZ2lOLURGUWtwTmM0anE1Z2RTNHRJcjgtU0RYWXRSTEMzYVFqVS1zVjlST0VUSXVRQ21zcU9HRkIzS3FEY2VR?oc=5","date":"2018-10-30","type":"trial","source":"Fierce Pharma","summary":"Invectys raises €15M series A to fund DNA cancer vaccine study in CLL - Fierce Pharma","headline":"Invectys raises €15M series A to fund DNA cancer vaccine study in CLL","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}